JUN and hepatocellular carcinoma: In Hepatocellular cancer (HCC)/liver cancer (LiC) cells, the integrin β1/α5/JNK/c-JUN signaling pathway participates in higher matrix stiffness, which is induced by LOXL2 (lysyl oxidase homolog 2).